In an agreement with Blue Earth and the University Hospital of Technical University of Munich (TUM), Siemens plans to evaluate the data to enhance its analytics and artificial intelligence-based algorithms for prostate cancer for its PET/CT imaging software.
F-18 rhPSMA-7.3 is a radiotracer synthesized by researchers at TUM, and it is being developed by Blue Earth. The tracer is currently being studied in two multicenter phase III trials, the company said.
Copyright © 2022 AuntMinnieEurope.com